ストックスクリーナーアプリを入手
36.35
2.94%
-1.10
Septerna Inc (SEPN) 最新ニュース
Septerna Officer Samira Shaikhly Files Form 144 to Sell 12,592 Common Shares - Kalkine Media
Officer Daniel Long proposes selling 10,001 Septerna (SEPN) common shares. - Stock Titan
An officer proposes selling 12,592 Septerna (SEPN) shares acquired by exercising stock options. - Stock Titan
Septerna, Inc.Common Stock (NQ: SEPN - The Chronicle-Journal
Septerna's CMO Rajiv Patni Granted 275,000 Stock Options with 10-Year Expiry - Kalkine Media
Septerna (SEPN) awards CMO 275,000 options at $37.37 - Stock Titan
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - manilatimes.net
Septerna Announces Inducement Grant Under Nasdaq Listing Rule - TradingView
A new medical chief gets an option to buy up to 275,000 Septerna shares at $37.37 - Stock Titan
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - lincolnjournal.com
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Carroll County Mirror-Democrat
Septerna at Cantor Fitzgerald conference: pipeline broadens, cash holds By Investing.com - Investing.com Canada
Septerna at Cantor Fitzgerald conference: pipeline broadens, cash holds - Investing.com India
Septerna at Wells Fargo conference: platform bets and pipeline catalysts By Investing.com - Investing.com Canada
Septerna SVP Daniel Long sells $126,077 in company stock By Investing.com - Investing.com South Africa
Septerna SVP Daniel Long sells $126,077 in company stock By Investing.com - Investing.com Nigeria
Septerna SVP Daniel Long sells $126,077 in company stock By Investing.com - Investing.com Canada
Septerna SVP Daniel Long sells $126,077 in company stock - Investing.com
Septerna SVP Daniel Long sells $126,077 in company stock By Investing.com - Investing.com India
New Septerna (SEPN) chief medical officer reports zero share holdings - Stock Titan
Septerna SVP Drug Discovery Daniel D. Long disposes of common shares worth $126,081.52 - Bitget
Septerna to Participate in Upcoming Investor Conferences - manilatimes.net
Septerna to Participate in Upcoming Investor Conferences - marketscreener.com
Septerna (SEPN) Declines 1.95% to $38.15, Approaching Key Support at $36.24Parabolic SAR - vinanet.vn
Septerna (SEPN) Declines 1.95% to $38.15, Approaching Key Support at $36.24Momentum Factor - dars.gov.et
Septerna Inc Q2 Income From Operations USD -1 - moomoo.com
Septerna (SEPN) Is Down 7.1% After Broad Russell Index Additions Has The Bull Case Changed? - sahmcapital.com
Septerna stock soars 315% on Novo Nordisk deal and key drug milestones - Pluang
Septerna appoints Rajiv Patni as chief medical officer By Investing.com - Investing.com Canada
Septerna Appoints Rajiv Patni as Chief Medical Officer - TipRanks
Septerna appoints Rajiv Patni as chief medical officer By Investing.com - Investing.com India
Septerna appoints Rajiv Patni as chief medical officer By Investing.com - Investing.com Nigeria
Septerna appoints Rajiv Patni as chief medical officer By Investing.com - Investing.com UK
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer - The Manila Times
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer - Barchart.com
Septerna (SEPN) Results at a Glance: The Bottom-Line Figure Outpaces Its Comparison in the Latest Reading; Market Response: The Share Price Adds 1.30% in the Latest SessionEarnings Beat Streak - siam.in
Septerna (SEPN) Results at a Glance: The Bottom-Line Figure Outpaces Its Comparison in the Latest Reading; Market Response: The Share Price Adds 1.30% in the Latest SessionMargin Guidance - dars.gov.et
Septerna (SEPN) Results at a Glance: The Bottom-Line Figure Outpaces Its Comparison in the Latest Reading; Market Response: The Share Price Adds 1.30% in the Latest SessionGuidance Revision Trend - vinanet.vn
Septerna (SEPN) Shares: Finishes 2.10% Higher at $40.84 for the Current Session; Immediate View: Support at $38.80 and Resistance at $42.88 Frame the Range in Latest TradingStandard Deviation - vinanet.vn
Septerna (SEPN) Shares: Finishes 2.10% Higher at $40.84 for the Current Session; Immediate View: Support at $38.80 and Resistance at $42.88 Frame the Range in Latest TradingSector ETF Flow - siam.in
Driehaus Capital Management Expands Septerna Inc (SEPN) Stake in Second Quarter - GuruFocus
Septerna (NASDAQ:SEPN) Stock Price Down 8%Time to Sell? - MarketBeat
Analysts Offer Insights on NA Companies: Cerebras Systems, Inc. Class A (CBRS), Septerna, Inc. (SEPN) and TWFG, Inc. Class A (TWFG) - theglobeandmail.com
SEPN Maintained by JP Morgan -- Price Target Raised to $48 - GuruFocus
Septerna (NASDAQ:SEPN) Price Target Raised to $48.00 - MarketBeat
J.P. Morgan Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $48 - Moomoo
SEPTERNA, INC. : JP MORGAN RAISES TARGET PRICE TO $48 FROM $38 - Bitget
4,211,659 Shares in Septerna, Inc. $SEPN Acquired by Trv Gp Vi LLC - MarketBeat
Trv Gp V LLC Takes Position in Septerna, Inc. $SEPN - MarketBeat
Septerna, Inc. (SEPN) Receives a Rating Update from a Top Analyst - The Globe and Mail
4.79%
大文字化:
|
ボリューム (24 時間):